Proton therapy for prostate cancer: is it worth it?
advertisement
Current Location:
>
> This Story

starstarstarstarstar (1)
Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Rad Oncology Homepage

MD Anderson to expand proton therapy center with $159 million project Increases accessibility to higher number of patients

Radiotherapy beats anti-hormonal therapy for some breast cancer patients, says study Avoiding side effects such as hot flashes, weight gain and bone fracture

New technique may concentrate radiotherapy dose for minimal tissue damage Utilizes very high energy electrons (VHEEs)

MedAustron delivers first bout of carbon ion therapy on patient Sixth center in the world to offer treatment

Research shows how hurricanes hinder radiotherapy outcomes Treatment transfers and eliminating out-of-network insurance charges could help

Elekta to distribute C-RAD SIGRT technology in North America and Mexico Advances stereotactic radiosurgery and stereotactic body radiotherapy

CMS proposes alternative payment model for radiation oncology Uses prospective, episode-based payments; ensures value-based care

FDA gives RaySearch green light for RayStation 8B platform First treatment planning system to offer machine learning applications

MedAustron to add health IT to proton and carbon ion treatment facilities Orders more than $13 million worth of RaySearch systems

'Nudge' in EHRs cuts imaging in half for palliative radiotherapy, says study Reduces duration of radiotherapy sessions

Florida Health Proton
Therapy Institute

Proton therapy for prostate cancer: is it worth it?

by Gus Iversen , Editor in Chief
While proton therapy has been lauded for its demonstrated superiority over more conventional treatments when it comes to high risk cancers — such as head and neck tumors and complex pediatric cases — the expensive treatment has been the subject of some debate when it comes to treating more commonplace indications such as prostate cancer.

One in seven men are expected to be diagnosed with prostate cancer in their lifetime, and although the disease is not usually fatal, the rate is high enough that it is the second leading cause of cancer death among U.S. men. The big question is about value: do the benefits of proton therapy for prostate cancer treatment justify the higher cost?

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



A new study from the University of Florida Health Proton Therapy Institute weighs in on the debate with new research that finds proton therapy is a highly effective treatment for low, intermediate, and high-risk prostate cancer.

"One of the major benefits of proton therapy, when compared to IMRT, is that proton therapy has the potential to reduce the risk for long term side effects," lead researcher and radiation oncologist, Dr. Curtis Bryant, told HCB News. "Consequently, proton therapy best serves patients with curable cancers where the expectation is for a long life following radiation therapy."

For advocates of proton therapy for prostate cancer, survival is not the end of the story. Quality of life can be jeopardized by long term complications or the development of a secondary cancer. For prostate cancer in particular, gastrointenstinal or urologic toxicity can have major repercussions on the post-treatment life of the patient.

"Our research describes the efficacy and safety of proton therapy in the management of prostate cancer for the entire medical community, which we feel will allow proton therapy to gain acceptance as an excellent treatment option for patients with prostate cancer," explained Bryant.

The study examined a cohort of 1,327 men who were treated at the University of Florida Health Proton Therapy Institute between 2006 and 2010 with median follow-up of five-and-a-half years.

Bryant said prostate cancer treatments currently account for 40 percent of the facility's proton therapy procedures.

The results showed no signs of cancer recurrence in 99 percent of low risk, 94 percent of intermediate risk, and 74 percent of high risk patients. In addition, less than 1 percent experienced serious gastroentestinal side effects and 3 percent experienced serious urologic side effects.
  Pages: 1 - 2 >>

Rad Oncology Homepage


(1)

Walton Justice

Proton Therapy

May 12, 2016 10:32

Happy to see such a positive article about proton therapy for prostate cancer. I am one of the first 100 patients in the study and I was rated as high risk Today I am still cancer free and without any of the side effects in traditional and even proton treatment protocols I am more than pleased that I chose UF for my cancer treatment

Log inor Register

to rate and post a comment

(14)

Gus Iversen

re: Proton Therapy

May 12, 2016 01:20

Thanks for your insights, Walton. As patients like you help establish the evidence that outcomes and QOL are superior, here's hoping access increases and costs come down.

Log inor Register

to rate and post a comment

You Must Be Logged In To Post A Comment